Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1957 Aug;32(164):313–317. doi: 10.1136/adc.32.164.313

Phenylketonuria with Normal Intelligence and Gowers' Muscular Dystrophy

Stephen Coates, A P Norman, L I Woolf
PMCID: PMC2012131  PMID: 13459459

Full text

PDF
313

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMSTRONG M. D., CARLISLE J. W., LOW N. L. Phenylketonuria; two unusual cases. Lancet. 1956 Nov 3;271(6949):917–918. [PubMed] [Google Scholar]
  2. ARMSTRONG M. D., ROBINSON K. S. On the excretion of indole derivatives in phenylketonuria. Arch Biochem Biophys. 1954 Sep;52(1):287–288. doi: 10.1016/0003-9861(54)90115-0. [DOI] [PubMed] [Google Scholar]
  3. ARMSTRONG M. D., TYLER F. H. Studies on phenylketonuria. I. Restricted phenylalanine intake in phenylketonuria. J Clin Invest. 1955 Apr;34(4):565–580. doi: 10.1172/JCI103105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BERRY J. P., WOOLF L. I. Estimation of phenylpyruvic acid. Nature. 1952 Feb 2;169(4292):202–203. doi: 10.1038/169202a0. [DOI] [PubMed] [Google Scholar]
  5. BICKEL H., GERRARD J., HICKMANS E. M. Influence of phenylalanine intake on phenylketonuria. Lancet. 1953 Oct 17;265(6790):812–813. doi: 10.1016/s0140-6736(53)90473-5. [DOI] [PubMed] [Google Scholar]
  6. BRAUDE H. Phenylketonuria; a case report in a European child treated with a diet low in phenylalanine. S Afr Med J. 1956 Jan 28;30(4):83–85. [PubMed] [Google Scholar]
  7. BRODIE B. B., AXELROD J., SHORE P. A., UDENFRIEND S. Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen. J Biol Chem. 1954 Jun;208(2):741–750. [PubMed] [Google Scholar]
  8. COWIE V. A. An atypical case of phenylketonuria. Lancet. 1951 Feb 3;1(6649):272–272. doi: 10.1016/s0140-6736(51)93320-x. [DOI] [PubMed] [Google Scholar]
  9. DALGLIESH C. E. Nonspecific formation of hydroxylated metabolites of the aromatic amino acids. Arch Biochem Biophys. 1955 Sep;58(1):214–226. doi: 10.1016/0003-9861(55)90108-9. [DOI] [PubMed] [Google Scholar]
  10. DANCIS J., BALIS M. E. A possible mechanism for disturbance in tyrosine metabolism in phenylpyruvic oligophrenia. Pediatrics. 1955 Jan;15(1):63–66. [PubMed] [Google Scholar]
  11. HORNER F. A., STREAMER C. W. Effect of a phenylalanine-restricted diet on patients with phenylketonuria; clinical observations in three cases. J Am Med Assoc. 1956 Aug 25;161(17):1628–1630. doi: 10.1001/jama.1956.62970170004005b. [DOI] [PubMed] [Google Scholar]
  12. KNOX W. E. The molecular concept of hereditary diseases. Bull Tufts N Engl Med Cent. 1956 Jan-Mar;2(1):1–8. [PubMed] [Google Scholar]
  13. PARE C. M., SANDLER M., STACEY R. S. 5-Hydroxytryptamine deficiency in phenylketonuria. Lancet. 1957 Mar 16;272(6968):551–553. doi: 10.1016/s0140-6736(57)90920-0. [DOI] [PubMed] [Google Scholar]
  14. PAULING L. Abnormality of hemoglobin molecules in hereditary hemolytic anemias. Harvey Lect. 1953;49:216–241. [PubMed] [Google Scholar]
  15. PENROSE L. S. Measurement of pleiotropic effects in phenylketonuria. Ann Eugen. 1951 Sep;16(2):134–141. doi: 10.1111/j.1469-1809.1951.tb02467.x. [DOI] [PubMed] [Google Scholar]
  16. UDENFRIEND S., BESSMAN S. P. The hydroxylation of phenylalanine and antipyrine in phenylpyruvic oligophrenia. J Biol Chem. 1953 Aug;203(2):961–966. [PubMed] [Google Scholar]
  17. WOOLF L. I., GRIFFITHS R., MONCRIEFF A. Treatment of phenylketonuria with a diet low in phenylalanine. Br Med J. 1955 Jan 8;1(4905):57–64. doi: 10.1136/bmj.1.4905.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. WOOLF L. I., VULLIAMY D. G. Phenylketonuria with a study of the effect upon it of glutamic acid. Arch Dis Child. 1951 Dec;26(130):487–494. doi: 10.1136/adc.26.130.487. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES